Availability of generic semaglutide removes barrier to affordable diabetes care, experts predict

In a caller investigation examining the economical implications of generic semaglutide entering the Canadian market, researchers foretell that anticipated terms reductions of up to 70% volition dramatically summation some the cost-effectiveness and wellness strategy affordability of therapy options for patients with benignant 2 diabetes and precocious cardiorenal risk.